| Pharmaceutical Information |
| Drug Name |
Deferoxamine |
| Drug ID |
BADD_D00596 |
| Description |
Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. |
| Indications and Usage |
Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions. |
| Marketing Status |
approved; investigational |
| ATC Code |
V03AC01 |
| DrugBank ID |
DB00746
|
| KEGG ID |
D03670
|
| MeSH ID |
D003676
|
| PubChem ID |
2973
|
| TTD Drug ID |
D0FJ8A
|
| NDC Product Code |
Not Available |
| UNII |
J06Y7MXW4D
|
| Synonyms |
Deferoxamine | Desferrioxamine | Desferioximine | Deferoxamine B | Desferrioxamine B | Deferoximine | Deferrioxamine B | Desferroxamine | Desferrioxamine B Mesylate | Mesylate, Desferrioxamine B | Deferoxamine Mesilate | Mesilate, Deferoxamine | Deferoxamine Mesylate | Mesylate, Deferoxamine | Deferoxamine Methanesulfonate | Methanesulfonate, Deferoxamine | Desferal |
|
| Chemical Information |
| Molecular Formula |
C25H48N6O8 |
| CAS Registry Number |
70-51-9 |
| SMILES |
CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
